Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. - Wikidata - wikimedia - TriplyDB

Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

http://www.wikidata.org/entity/Q37313068

about

Hypoplastic left heart syndrome: current considerations and expectations The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection Antibody-mediated rejection: emergence of animal models to answer clinical questions The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection.Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.Antibody-mediated rejection: an evolving entity in heart transplantation.Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.Report from a consensus conference on antibody-mediated rejection in heart transplantation Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group Antibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelines Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.Management of heart transplant recipients: reference for primary care physicians.Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Immunosuppression following heart transplantation: prospects and challenges.Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification.Heart transplantation: review.The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions.Immunosuppression and adult heart transplantation: emerging therapies and opportunities.Biomarkers of acute rejection following cardiac transplantation.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.New issues in heart transplantation for heart failure.Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation.Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?Evolving concepts and treatment strategies for cardiac allograft vasculopathy.Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation.Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients.Corticosteroid wean after heart transplantation-Is there a risk for antibody formation?Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection.Current Expectations for Cardiac Transplantation in Patients With Congenital Heart Disease.

P2860

Q26821904-34D41092-92DB-4F7F-8121-2D215FBCCB84 Q26862195-3F2910DA-2460-4014-BF7A-BEF8CCAE9F4D Q27692014-5F637656-51D1-4506-8FA1-0E331C0947BC Q33911449-A6E14273-8712-4A9B-9C5F-327A29CDA960 Q34238488-43CD8EC0-A66D-40E8-ACD1-C76405928947 Q34257142-9463BD42-15B4-4066-8B46-B4D44CCFD39B Q35790552-8AF0DEA2-2FFB-47D6-B1B3-FB6F4E89A4F3 Q35876250-24026D99-2D08-45C2-8B81-1231C83311FA Q36584512-5B7361FF-7DFE-4C80-B07A-2B710F9DE062 Q37029903-B9121550-89DB-45DB-A581-06C5D53FEF5C Q37044200-9E0FD875-C342-4D6A-B99B-B6D0AB636DB6 Q37313051-C8310F77-EDBA-4AE5-BF50-83FF4D6B3528 Q37346571-50640F2D-BD3A-40AA-A57A-E02E036E1F82 Q37524481-05EA5205-26B8-44CA-9DBE-F5DBF56EC2A0 Q37969113-C5096415-429D-4FFC-8ADA-8ABBA802EF1D Q38032621-5A1D51F4-982E-4DF7-B898-A495D9632E2F Q38036785-055D2CC9-3F24-43D8-B9D7-EFB58C6849AB Q38123309-E65EADE3-D7BE-4E0F-8BB2-A8F4CE0F2529 Q38184649-600FFB96-D599-493C-94BF-AE2B7BACD82A Q38210159-8B2E15C3-1955-4D04-811F-7F58AE64EBE5 Q38543941-547412E3-26E0-427E-BDCF-FD413B3D8D77 Q38793606-059D5B3B-9F9A-4F0A-9014-219942324C9A Q39029380-07417CC7-E8B3-4937-BCAF-BD3F6183BBC1 Q39128537-D5B4A958-6CF6-4A38-81C2-4885B00B3656 Q39217968-4DAF8899-11A1-4565-AF01-070430622F3F Q39366396-489C6240-73ED-4470-8800-03FF72DBB6EE Q39610198-20F66B25-EA00-4B4A-A497-1C14A5AC3EF4 Q40108113-D87790EC-1CBB-408A-AAF2-174084D999AA Q40331013-84E96CE7-3349-4711-89FE-4886E90ECB1A Q41349670-87581206-05D7-4D0E-9A92-604D3F57F248 Q41849097-7F862012-02CD-4462-8804-CFFCE2141D4D Q44055243-3D705D9C-4CFB-41C0-82B2-15A4829745B7 Q47613394-7C87EC4C-78AE-4C50-AED1-8DF8EF1DA562 Q48149010-2B1174EC-036E-4338-853F-96B7D940F42F Q48165787-6E761FBE-AC5D-405C-8530-1D2172892ACD Q48215946-9B15F699-8BC9-4182-9584-A212C349A481 Q48259861-2D1C32E3-586A-4332-B67C-48ADBFFB3760 Q48297414-B89C6C4D-2534-42BE-A97A-1C2977AED2B9 Q50910367-6F599F51-5507-4943-9637-717B961BD1AA Q51102400-A4F31215-98A8-4C06-8254-8944D52FAC65

P2860

Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

http://www.wikidata.org/entity/Q37313068

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Asymptomatic antibody-mediated ...... tation predicts poor outcomes.

@en

Asymptomatic antibody-mediated ...... tation predicts poor outcomes.

@nl

type

label

Asymptomatic antibody-mediated ...... tation predicts poor outcomes.

@en

Asymptomatic antibody-mediated ...... tation predicts poor outcomes.

@nl

prefLabel

Asymptomatic antibody-mediated ...... tation predicts poor outcomes.

@en

Asymptomatic antibody-mediated ...... tation predicts poor outcomes.

@nl

P1433

Q37313068-989FD887-7D03-4564-BB16-46E654EC452B

P1476

Q37313068-CA5B6BDD-5519-40C7-B9EC-ADBB013ECE61

P2093

Q37313068-0F28CFB6-5499-41DA-A747-AEAF14C7ABFF

Q37313068-2B342C75-AE8C-4B5C-9ABC-655BCD9FE29F

Q37313068-534D5999-F5C5-441B-AEDB-FE7929FC31DA

Q37313068-6127C441-44D8-436A-9415-F48A37B749ED

Q37313068-97E35940-617D-40BC-8406-D392314E0633

Q37313068-C196E41F-546C-4197-8A6E-76B6BC0DED2E

Q37313068-C31DECD0-9385-4A53-9896-67585CA6E37E

P2860

Q37313068-085D81B2-F92E-4917-AEBC-F11607E1CCC7

Q37313068-085DFB23-3B5C-46A6-B26F-11006F9F2985

Q37313068-0A2E62D1-A1FE-4080-B260-0C1FFA77E783

Q37313068-2BF1ADE1-861E-4371-92AE-38D80511C88B

Q37313068-30917D6C-FDAB-402E-B99F-F0CB0E4F9719

Q37313068-38E73B1A-568D-451A-8581-344A051AE5BF

Q37313068-537EA71E-AE18-4A24-8081-06C704FDDCB4

Q37313068-58435DBB-8326-48EE-83C2-FDA7501E42D4

Q37313068-58A4B2ED-0DEE-4E27-899D-A0E247CB196E

Q37313068-8474FB4E-39F6-4A7E-B09A-AEC3CE325E0B

P304

Q37313068-DF387771-6283-4FCD-95DF-F99FB40F3084

P31

Q37313068-07B7E23B-F459-47A4-BF56-38C24E4E2DF5

P356

Q37313068-094B8116-CF43-4692-8555-934D9977C82B

P433

Q37313068-4D3F193A-50AA-411C-87F4-C8A721240251

P478

Q37313068-C290061C-3F9A-4FB2-AE2B-A2B86B8EB8D2

P50

Q37313068-558CF17A-15E2-4337-BFB4-96A944A94404

P577

Q37313068-2C36218C-0AFC-4738-A3EF-FDDC162DA480

P698

Q37313068-137CEAE2-D693-4584-9556-2F4F84BEC2D7

P921

Q37313068-8341D2AF-1C20-4A5C-A790-EC15C13197D4

P932

Q37313068-A862DF90-D536-40C4-89F4-FA4124FA6D88

P356

J.HEALUN.2009.01.015

P1433

The Journal of Heart and Lung Transplantation

P1476

Asymptomatic antibody-mediated ...... ntation predicts poor outcomes

@en

P2093

Abbas Ardehali

http://www.w3.org/2001/XMLSchema#string

Elaine F Reed

http://www.w3.org/2001/XMLSchema#string

Grace W Wu

http://www.w3.org/2001/XMLSchema#string

Jignesh K Patel

http://www.w3.org/2001/XMLSchema#string

Krista K Kiyosaki

http://www.w3.org/2001/XMLSchema#string

Michael C Fishbein

http://www.w3.org/2001/XMLSchema#string

Michelle M Kittleson

http://www.w3.org/2001/XMLSchema#string

P2860

Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

Humoral rejection of human organ transplants.

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Optimizing the immunosuppressive regimen in heart transplantation.

Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?

Antibody-mediated organ-allograft rejection.

Acute antibody-mediated rejection of cardiac transplants.

Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.

P304

417-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HEALUN.2009.01.015

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Jon A Kobashigawa

P577

2009-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19416767

http://www.w3.org/2001/XMLSchema#string

P921

P932

3829690

http://www.w3.org/2001/XMLSchema#string